VONTARG
DEAD

Serial Number

79203134

Owner

NOVARTIS AG

Filing Date

Dec 10, 2016

Add to watchlist:

No watchlists yet
View on USPTO

VONTARG Trademark

Serial Number: 79203134

VONTARG is a trademark filed by NOVARTIS AG on December 10, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

December 10, 2016

Registration Date

Not Registered

Published for Opposition

June 13, 2017

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 21, 2018 FINV
NOTIFICATION PROCESSED BY IB
Sep 21, 2018 GPNX
REFUSAL PROCESSED BY IB
Apr 13, 2018 RFNT
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jul 29, 2017 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 28, 2017 DETH
PUBLISHED FOR OPPOSITION
Jun 13, 2017 PUBO
NOTICE OF PUBLICATION
May 24, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 2, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 2, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 2, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 2, 2017 TROA
REFUSAL PROCESSED BY IB
Apr 28, 2017 RFNT
APPLICATION FILING RECEIPT MAILED
Mar 18, 2017 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 17, 2017 RFCS
REFUSAL PROCESSED BY MPU
Mar 17, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 16, 2017 RFCR
NON-FINAL ACTION WRITTEN
Mar 15, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 10, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 9, 2017 SDRC